A study by Schlereth et al. demonstrated that inhibition of CCR7 with a topical CCR7 antagonist ameliorated the clinical expressions of allergic conjunctivitis in immunized mice [179]. The gene discussed is CCR7; the disease is atopic conjunctivitis.